Back to Annual Meeting
Back to Annual Meeting
APHA Scientific Session and Event Listing
Edward Morse, PhD1, Patricia M. Morse, PhD2, Samuel Burgess, MA, MPH3, and Stan Hoogerwerf, MA2. (1) Pediatrics, Tulane University, 1430 Tulane Ave SL-37, New Orleans, LA 70112, 828.260.2873, email@example.com, (2) Psychiatry, LSU Health Sciences Center, 1542 Tulane Ave, New Orleans, LA 70112, (3) Louisiana Office of Public Health, 10 10 Common St, New Orleans, LA 70112
Objective: To examine the differential effects of self-efficacy and self-esteem on stimulating readiness to change HIV/HCV sexual and drug use risk behaviors in a cohort of young African American IDUs participating in a longitudinal study comparing the relative efficacy of 3 HIV/HCV risk reduction interventions. Methods: As part of a NIDA-funded risk reduction intervention study 211 incarcerated young African American IDUs were randomized to one of three intervention arms (counseling and testing (CT), pharmacy syringe purchase (PSP), and a client centered behavioral intervention (CCBI)). HIV, HCV, and Chlamydia laboratory data as well as baseline interview data measuring readiness to change, self-esteem, self-efficacy, and sexual and drug use risk behaviors were compared to parallel data gathered 6 months post incarceration. Results: At 6 month follow-up, syringe sharing was significantly reduced across all interventions by at least 25%. Increased self-efficacy and self-esteem resulted in increased readiness to change (r=.72; p<.01; r=.68; p<.01 respectively) which was significantly positively associated with HIV/HCV risk reduction (r=.71; p<.01). Conclusions: HIV/HCV risk reduction interventions that include increasing self-efficacy and self-esteem are likely to result in significant HIV/HCV risk behavior change and should be included in intervention and prevention efforts
Keywords: Intravenous Drug Use, HIV/AIDS
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.